This conceptual shift has translational implications: pharmacological activation of Epac1, selective enhancement of Rap1/Rac1 signaling, or targeted suppression of RhoA/ROCK during the repair phase could accelerate endothelial sealing in acute inflammatory settings such as sepsis, ischemia–reperfusion injury, or acute lung injury. The gene discussed is RAPGEF3; the disease is Sepsis.